Brandon Capital, Australasia’s leading life sciences venture capital firm, today announced the final close of its sixth fund at $439 million.
Interview
New Stories
-
Australian Life Sciences Venture Capital firm Brandon Capital announces Fund Six final close
July 24, 2025 - - AusBiotech -
Sanofi to acquire Vicebio, gaining rights to Queensland discovered technology
July 23, 2025 - - Latest News -
OncoSil Medical completes recruitment in TRIPP-FFX clinical trial
July 23, 2025 - - Latest News -
Nyrada advances Xolatryp towards Phase 2a trial in cardioprotection
July 23, 2025 - - Latest News -
Amplia Therapeutics announces $25 million placement and launches share purchase plan
July 23, 2025 - - Latest News -
Percheron Therapeutics announces publication of new preclinical HMBD-002 data
July 23, 2025 - - Latest News -
Radiopharm Theranostics announces new appointment to advisory board
July 22, 2025 - - Latest News